SeaStar Medical Holding Co. (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 518,200 shares, an increase of 53.3% from the November 30th total of 338,100 shares. Currently, 12.1% of the company’s stock are sold short. Based on an average daily trading volume, of 203,700 shares, the short-interest ratio is currently 2.5 days.

SeaStar Medical Stock Down 2.4 %

ICU traded down $0.05 during trading on Friday, hitting $2.04. 129,912 shares of the company traded hands, compared to its average volume of 215,122. The firm has a market cap of $9.10 million, a P/E ratio of -0.18 and a beta of -1.13. SeaStar Medical has a one year low of $1.69 and a one year high of $42.92. The stock’s fifty day moving average is $2.52 and its 200 day moving average is $4.88.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.